کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
10162516 1114333 2013 11 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Effects of Temperature and Osmolytes on Competing Degradation Routes for an IgG1 Antibody
موضوعات مرتبط
علوم پزشکی و سلامت داروسازی، سم شناسی و علوم دارویی اکتشاف دارویی
پیش نمایش صفحه اول مقاله
Effects of Temperature and Osmolytes on Competing Degradation Routes for an IgG1 Antibody
چکیده انگلیسی
Addition of excipients is a common strategy to slow protein aggregation during storage. Excipient effects on the mechanism(s) and temperature (T) dependence of aggregation for a monoclonal antibody solution were tested using size-exclusion chromatography, differential scanning calorimetry (DSC), temperature scanning monomer loss (TSML), and laser light scattering; previous work in buffer-only conditions had shown non-Arrhenius behavior and implicated Fab and/or CH3 unfolding as a key step in aggregation. Excipients included citrate, amino acid salts (histidine-HCl, arginine-HCl), and polyols (mannitol and glycerol). DSC and TSML showed that Fab, rather than CH3, unfolding corresponded with the onset of aggregation for each condition. Isothermal incubation at 56.5°C, 40°C, and 2°C-8°C resulted in aggregation, while fragmentation occurred readily at only 40°C. The primary effect of the different excipients appeared to be preferential accumulation/exclusion, affecting the concentrations of partially unfolded monomer key intermediates. In addition, aggregation rates were clearly non-Arrhenius, causing aggregation to dominate over fragmentation at high and low T, and making long-term stability predictions problematic based on commonly employed 40°C conditions. Possible reasons for non-Arrhenius behavior include a strong T-dependence of the Fab unfolding enthalpy and/or a switch from Fab-mediated to Fc-mediated aggregation as one moves from high to low T.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Pharmaceutical Sciences - Volume 102, Issue 10, October 2013, Pages 3556-3566
نویسندگان
, , ,